Public Affairs – fostering knowledge transfer between industry and public stakeholders
Our public affairs team aspires to be a leader in responsibility and transparency in the public policy process regarding medicinal cannabis and the cannabis legalization for adult-use.
We are committed to open and transparent discussions that advance the discourse on facts, create a safe and better future for our partners, customers and patients in order to promote trust in the European cannabis industry.
We are proud member of key associations within the cannabis industry, furthering our commitment to excellence and collaboration. As a board member (“Vorstandsmitglied”) of the BPC (Federal Association of Pharmaceutical Cannabinoid Companies), we actively contribute to shaping the voice of pharmaceutical cannabinoid companies in Germany. Furthermore, as a supporting member (“Fördermitglied”) of the VCA (Association of Cannabis Supplying Pharmacies e.V.), we are at the forefront of ensuring quality cannabis care through pharmacies. These partnerships underscore our dedication to leading the industry forward with integrity and expertise.
In addition to our focus on ethical business practices, we prioritize compliance with all relevant laws and regulations in the industry, including registering our lobbying activities and working in accordance with state code of conduct.
Find our latest publications and political letters here.
Press contact
Press
notices
Keep up to date with the latest news from Cansativa – from product launches and successes to our latest positions on current developments.
25. September 2024
Thanks to Cansativa: Cookies products are now available in Germany!
"Yes, we can Cannabizz" – Berner is coming to Germany on November 14th.
11. June 2024
Cansativa and Cookies team up to bring Cookies products into the German medical cannabis market.
Cansativa Group will exclusively distribute Cookies-branded medical cannabis products across Germany starting 1st of August 2024
30. October 2023
Cansativa and Cronos Group Inc. launch leading medical cannabis brand PEACE NATURALS® in Germany
Cansativa will import, distribute, and market Cronos brand PEACE NATURALS® Frankfurt am Main, 30th of October 2023
Company presentation
to download
UP 2024
PDF-Datei (2,3 MB)
Read
our cannabis
Briefing.
Stay up to date on the latest developments in medical cannabis and the legalization process for adult recreational use.
5. December 2024
Green Rush or Consolidation? The German Medical Cannabis Market in Focus
Is Germany's medical cannabis market booming or heading toward consolidation? Discover the latest Cannabis Briefing for insights into the…
21. November 2024
Looking Back on ‘Yes, We Can Cannabizz’ – An Evening Shaping the Future of Medical Cannabis
Cansativa’s "Yes, We Can Cannabizz" event in Berlin brought together industry leaders, medical experts, and patients to discuss the future of…
31. October 2024
Milestones and Future Visions: 100 Editions of the Cannabis Briefing
Research lies at the heart of advancements in cannabis and medical cannabis. Thorough scientific studies not only enhance therapeutic understanding…
27. September 2024
How the 2024 US Elections Could Impact Cannabis Regulation
In today’s Cannabis Briefing, we look beyond our usual scope and explain why the US elections hold international significance, particularly for…
5. September 2024
Cansativa Expert Dialogue: An Interview with Aline Gralke
Last year, Switzerland launched its first pilot projects to study the recreational use of cannabis. In today’s edition of the Cannabis Briefing, we…
15. August 2024
Slow but Steady: Europe’s Evolving Cannabis Landscape
While Germany has taken the bold step of decriminalizing cannabis for recreational purposes, signaling a major shift in European drug policy, its…
1. August 2024
G-BA Decision on Medical Cannabis – A Win for Patients
Excitement is widespread in the medical cannabis community and among patients. On July 18, the Federal Joint Committee (Gemeinsamer Bundesausschuss…
19. July 2024
The Future of Medical Cannabis: A Review after 100 Days of Decriminalization in Germany
It's been 100 days since cannabis was decriminalized in Germany, and the landscape is evolving rapidly. As of this month, cultivation clubs in…
4. July 2024
The Importance of the EU-Monograph on Cannabis Flowers for Patients across Europe
In this edition of our Cannabis Briefing, we explore a development that promises to reshape the landscape of medical cannabis across Europe—not…
13. June 2024
Cansativa Expert Dialogue: An Interview with Melanie Dolfen, Pharmacist and Pioneer in Medicinal Cannabis
In today’s edition of The Cannabis Briefing, we delve deeper into the current challenges and developments in the realm of medicinal cannabis. We had…
Position papers
& Publications
Our position papers address many of the most important issues in our business area. They transparently explain our company position and current assessment on specific topics
Q4 2022 | Position paper
PDF file (188 KB)
Known from
Explore Our Cannabis Briefing
Stay ahead with the latest insights in medical cannabis, political decisions, industry news, and research advances.
Stay informed!
Our newsletter is designed to keep you informed and ahead in the rapidly evolving world of medical cannabis. The Cannabis Briefing is your essential resource for the latest research findings, regulatory updates, market trends, and advocacy efforts shaping the future of cannabis.